cloudfront

Report Detail



Pharma & HealthcareGlobal Basal Cell Carcinoma Treatment Market Insights, Forecast to 2025

  • RnM2315938
  • |
  • 8 August, 2018
  • |
  • Global
  • |
  • 95 pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Global Basal Cell Carcinoma Treatment Market Insights, Forecast to 2025

Table of Contents

    1 Study Coverage

    • 1.1 Basal Cell Carcinoma Treatment Product
    • 1.2 Key Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Basal Cell Carcinoma Treatment Market Size Growth Rate by Type
      • 1.4.2 Surgical Excision
      • 1.4.3 Electrodessication & Cutterage
      • 1.4.4 Moh's Surgery
      • 1.4.5 Cryosurgery
    • 1.5 Market by Application
      • 1.5.1 Global Basal Cell Carcinoma Treatment Market Size Growth Rate by Application
      • 1.5.2 Hospitals
      • 1.5.3 Specialty Clinics
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Basal Cell Carcinoma Treatment Market Size
      • 2.1.1 Global Basal Cell Carcinoma Treatment Revenue 2016-2025
      • 2.1.2 Global Basal Cell Carcinoma Treatment Sales 2016-2025
    • 2.2 Basal Cell Carcinoma Treatment Growth Rate by Regions
      • 2.2.1 Global Basal Cell Carcinoma Treatment Sales by Regions
      • 2.2.2 Global Basal Cell Carcinoma Treatment Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Basal Cell Carcinoma Treatment Sales by Manufacturers
      • 3.1.1 Basal Cell Carcinoma Treatment Sales by Manufacturers
      • 3.1.2 Basal Cell Carcinoma Treatment Sales Market Share by Manufacturers
      • 3.1.3 Global Basal Cell Carcinoma Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2 Basal Cell Carcinoma Treatment Revenue by Manufacturers
      • 3.2.1 Basal Cell Carcinoma Treatment Revenue by Manufacturers (2016-2018)
      • 3.2.2 Basal Cell Carcinoma Treatment Revenue Share by Manufacturers (2016-2018)
    • 3.3 Basal Cell Carcinoma Treatment Price by Manufacturers
    • 3.4 Basal Cell Carcinoma Treatment Manufacturing Base Distribution, Product Types
      • 3.4.1 Basal Cell Carcinoma Treatment Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Basal Cell Carcinoma Treatment Product Category
      • 3.4.3 Date of International Manufacturers Enter into Basal Cell Carcinoma Treatment Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type

    • 4.1 Global Basal Cell Carcinoma Treatment Sales by Type
    • 4.2 Global Basal Cell Carcinoma Treatment Revenue by Type
    • 4.3 Basal Cell Carcinoma Treatment Price by Type

    5 Breakdown Data by Application

    • 5.1 Overview
    • 5.2 Global Basal Cell Carcinoma Treatment Breakdown Data by Application

    6 North America

    • 6.1 North America Basal Cell Carcinoma Treatment by Countries
      • 6.1.1 North America Basal Cell Carcinoma Treatment Sales by Countries
      • 6.1.2 North America Basal Cell Carcinoma Treatment Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Basal Cell Carcinoma Treatment by Type
    • 6.3 North America Basal Cell Carcinoma Treatment by Application
    • 6.4 North America Basal Cell Carcinoma Treatment by Company

    7 Europe

    • 7.1 Europe Basal Cell Carcinoma Treatment by Countries
      • 7.1.1 Europe Basal Cell Carcinoma Treatment Sales by Countries
      • 7.1.2 Europe Basal Cell Carcinoma Treatment Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Basal Cell Carcinoma Treatment by Type
    • 7.3 Europe Basal Cell Carcinoma Treatment by Application
    • 7.4 Europe Basal Cell Carcinoma Treatment by Company

    8 Asia Pacific

    • 8.1 Asia Pacific Basal Cell Carcinoma Treatment by Countries
      • 8.1.1 Asia Pacific Basal Cell Carcinoma Treatment Sales by Countries
      • 8.1.2 Asia Pacific Basal Cell Carcinoma Treatment Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Basal Cell Carcinoma Treatment by Type
    • 8.3 Asia Pacific Basal Cell Carcinoma Treatment by Application
    • 8.4 Asia Pacific Basal Cell Carcinoma Treatment by Company

    9 Central & South America

    • 9.1 Central & South America Basal Cell Carcinoma Treatment by Countries
      • 9.1.1 Central & South America Basal Cell Carcinoma Treatment Sales by Countries
      • 9.1.2 Central & South America Basal Cell Carcinoma Treatment Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Basal Cell Carcinoma Treatment by Type
    • 9.3 Central & South America Basal Cell Carcinoma Treatment by Application
    • 9.4 Central & South America Basal Cell Carcinoma Treatment by Company

    10 Middle East and Africa

    • 10.1 Middle East and Africa Basal Cell Carcinoma Treatment by Countries
      • 10.1.1 Middle East and Africa Basal Cell Carcinoma Treatment Sales by Countries
      • 10.1.2 Middle East and Africa Basal Cell Carcinoma Treatment Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Basal Cell Carcinoma Treatment by Type
    • 10.3 Middle East and Africa Basal Cell Carcinoma Treatment by Application
    • 10.4 Middle East and Africa Basal Cell Carcinoma Treatment by Company

    11 Company Profiles

    • 11.1 Sun Pharmaceuticals
      • 11.1.1 Sun Pharmaceuticals Company Details
      • 11.1.2 Company Description
      • 11.1.3 Sales, Revenue and Gross Margin of Basal Cell Carcinoma Treatment
      • 11.1.4 Basal Cell Carcinoma Treatment Product Description
      • 11.1.5 Recent Development
    • 11.2 Valeant Pharmaceuticals International
      • 11.2.1 Valeant Pharmaceuticals International Company Details
      • 11.2.2 Company Description
      • 11.2.3 Sales, Revenue and Gross Margin of Basal Cell Carcinoma Treatment
      • 11.2.4 Basal Cell Carcinoma Treatment Product Description
      • 11.2.5 Recent Development
    • 11.3 Mylan N.V.
      • 11.3.1 Mylan N.V. Company Details
      • 11.3.2 Company Description
      • 11.3.3 Sales, Revenue and Gross Margin of Basal Cell Carcinoma Treatment
      • 11.3.4 Basal Cell Carcinoma Treatment Product Description
      • 11.3.5 Recent Development
    • 11.4 F. Hoffmann-La Roche Ltd
      • 11.4.1 F. Hoffmann-La Roche Ltd Company Details
      • 11.4.2 Company Description
      • 11.4.3 Sales, Revenue and Gross Margin of Basal Cell Carcinoma Treatment
      • 11.4.4 Basal Cell Carcinoma Treatment Product Description
      • 11.4.5 Recent Development
    • 11.5 Merck & Co.
      • 11.5.1 Merck & Co. Company Details
      • 11.5.2 Company Description
      • 11.5.3 Sales, Revenue and Gross Margin of Basal Cell Carcinoma Treatment
      • 11.5.4 Basal Cell Carcinoma Treatment Product Description
      • 11.5.5 Recent Development

    12 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 12.1 Market Opportunities and Drivers
    • 12.2 Market Challenges
    • 12.3 Market Risks/Restraints
    • 12.4 Key World Economic Indicators

    13 Value Chain and Sales Channels Analysis

    • 13.1 Value Chain Analysis
      • 13.1.1 Typical Suppliers of Key Basal Cell Carcinoma Treatment Raw Material
      • 13.1.2 Basal Cell Carcinoma Treatment Customers
    • 13.2 Sales Channels Analysis
      • 13.2.1 Sales Channels Analysis
      • 13.2.2 Distributors

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Author Details

      This report studies the global market size of Basal Cell Carcinoma Treatment in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Basal Cell Carcinoma Treatment in these regions.
      This research report categorizes the global Basal Cell Carcinoma Treatment market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

      Basal cell carcinoma has a low metastasis rate and is more benign, so it is also called basal cell epithelial tumor. Based on its greater destructiveness, it is also called invasive ulcer. Basal cell carcinoma is more common in the elderly, and it occurs in the head, face, neck and back of the hand, especially the prominent part of the face. It begins with a small nodule that is skin-to-dark-infiltrated, typically waxy, translucent nodules with high curled edges. The central part begins to rupture, with black necrotic sputum, and the central necrosis spreads to the deep tissue, showing large invasive necrosis, which can reach soft tissue and bone tissue.
      Among the many treatments, surgical resection is still the most effective treatment for the complete eradication of basal cell carcinoma and avoiding tumor recurrence.
      In addition to surgical resection, other methods that can be used to treat basal cell carcinoma include: radiation therapy, photodynamic therapy, scraping electrocautery, cryotherapy, topical application of drugs, etc.
      In 2017, the global Basal Cell Carcinoma Treatment market size was 4520 million US$ and is forecast to 9090 million US in 2025, growing at a CAGR of 9.1% from 2018. The objectives of this study are to define, segment, and project the size of the Basal Cell Carcinoma Treatment market based on company, product type, application and key regions.

      The various contributors involved in the value chain of Basal Cell Carcinoma Treatment include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Basal Cell Carcinoma Treatment include
      Sun Pharmaceuticals
      Valeant Pharmaceuticals International
      Mylan N.V.
      F. Hoffmann-La Roche Ltd
      Merck & Co.

      Market Size Split by Type
      Surgical Excision
      Electrodessication & Cutterage
      Moh's Surgery
      Cryosurgery
      Market Size Split by Application
      Hospitals
      Specialty Clinics
      Others

      Market size split by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Basal Cell Carcinoma Treatment market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
      To understand the structure of Basal Cell Carcinoma Treatment market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Basal Cell Carcinoma Treatment manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
      To analyze the Basal Cell Carcinoma Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
      To project the value and volume of Basal Cell Carcinoma Treatment submarkets, with respect to key regions (along with their respective key countries).
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
      To strategically profile the key players and comprehensively analyze their growth strategies.

      In this study, the years considered to estimate the market size of Basal Cell Carcinoma Treatment are as follows:
      History Year: 2013-2017
      Base Year: 2017
      Estimated Year: 2018
      Forecast Year 2018 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Basal Cell Carcinoma Treatment market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.




      Summary:
      Get latest Market Research Reports on Basal Cell Carcinoma Treatment. Industry analysis & Market Report on Basal Cell Carcinoma Treatment is a syndicated market report, published as Global Basal Cell Carcinoma Treatment Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Basal Cell Carcinoma Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $7,800.00
      2,618.85
      5,237.70
      3,588.78
      7,177.56
      472,446.00
      944,892.00
      258,622.26
      517,244.52
      Add To Cart Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report